Radius Health Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
28. April 2020 16:35 ET
|
Radius Health Inc.
WALTHAM, Mass., April 28, 2020 (GLOBE NEWSWIRE) -- Radius Health, Inc. (“Radius” or the “Company”) (Nasdaq:RDUS) today announced that the Company’s Board of Directors (the “Board”) granted G. Kelly...
Radius Health Announces CEO Leadership Transition
28. April 2020 16:30 ET
|
Radius Health Inc.
Jesper Hoeiland to step down as President and Chief Executive Officer in order to return to Denmark with his family Jesper will serve as a Senior Advisor to the Company to help facilitate a smooth...
Radius Health to Announce First Quarter 2020 Financial Results, Host Conference Call and Live Webcast on Thursday May 7, 2020
20. April 2020 16:15 ET
|
Radius Health Inc.
WALTHAM, Mass., April 20, 2020 (GLOBE NEWSWIRE) -- Radius Health (Nasdaq: RDUS) announced today that it will release its first quarter financial results on Thursday, May 7, 2020. The Company will...
Radius Health to Present at Cowen 40th Annual Healthcare Conference
03. März 2020 09:15 ET
|
Radius Health Inc.
WALTHAM, Mass., March 03, 2020 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS), today announced that Jesper Høiland, President & CEO and Pepe Carmona, CFO will present a corporate update...
Radius Health Announces Fourth Quarter and Full-Year 2019 Operating Results
27. Februar 2020 07:30 ET
|
Radius Health Inc.
TYMLOS® U.S. net sales grew to $56 million in the fourth quarter of 2019, totaling $173M for full-year 2019, exceeding the Company’s guidance of $168 to 172M TYMLOS exited 2019 with majority...
Radius Health to Announce Fourth Quarter and Full Year 2019 Financial Results, Host Conference Call and Live Webcast on Thursday, February 27, 2020
13. Februar 2020 16:05 ET
|
Radius Health Inc.
WALTHAM, Mass., Feb. 13, 2020 (GLOBE NEWSWIRE) -- Radius Health (Nasdaq: RDUS) announced today that it will release its fourth quarter and full year 2019 financial results on Thursday, February 27,...
Radius Health to Present at 9th Annual SVB Leerink Partners Global Healthcare Conference
13. Februar 2020 16:05 ET
|
Radius Health Inc.
WALTHAM, Mass., Feb. 13, 2020 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS), today announced that Jesper Høiland, President & CEO and Pepe Carmona, CFO will present a corporate update...
Radius Exceeds 2019 Financial Guidance and Provides Business Update at the 38th Annual J.P. Morgan Healthcare Conference
13. Januar 2020 09:00 ET
|
Radius Health Inc.
Full-Year 2019 TYMLOS U.S. net revenue exceeds financial guidance, surpassing $172M. TYMLOS exits 2019 with 52% market share in new patients1, on track for market leadership in 2020. Radius delivers...
Radius Health to Present at the 38th Annual J.P. Morgan Healthcare Conference
06. Januar 2020 16:14 ET
|
Radius Health Inc.
WALTHAM, Mass., Jan. 06, 2020 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS), today announced that its senior executive management team will present a corporate update at the 38th Annual...
Radius Health Announces Scientific Presentations at 2019 San Antonio Breast Cancer Symposium (SABCS)
06. Dezember 2019 09:47 ET
|
Radius Health Inc.
WALTHAM, Mass., Dec. 06, 2019 (GLOBE NEWSWIRE) -- Radius Health, Inc. (“Radius” or the “Company”) (Nasdaq: RDUS) today announced its scientific presentations on elacestrant and RAD140 at the...